Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

BIO-TECHNE (TECH) Equity Income: 2023-2025

Historic Equity Income for BIO-TECHNE (TECH) over the last 2 years, with Sep 2025 value amounting to $294,000.

  • BIO-TECHNE's Equity Income fell 21.39% to $294,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $858,000, marking a year-over-year increase of 120.54%. This contributed to the annual value of $938,000 for FY2025, which is 113.71% up from last year.
  • BIO-TECHNE's Equity Income amounted to $294,000 in Q3 2025, which was down 73.44% from $1.1 million recorded in Q2 2025.
  • In the past 5 years, BIO-TECHNE's Equity Income registered a high of $1.1 million during Q2 2025, and its lowest value of -$2.3 million during Q3 2023.
  • In the last 3 years, BIO-TECHNE's Equity Income had a median value of -$589,000 in 2025 and averaged -$623,333.
  • The largest annual percentage gain for BIO-TECHNE's Equity Income in the last 5 years was 224.24% (2025), contrasted with its biggest fall of 21.39% (2025).
  • BIO-TECHNE's Equity Income (Quarterly) stood at -$1.9 million in 2023, then soared by 102.40% to $46,000 in 2024, then dropped by 21.39% to $294,000 in 2025.
  • Its Equity Income was $294,000 in Q3 2025, compared to $1.1 million in Q2 2025 and -$589,000 in Q1 2025.